On 07 May 2018
Pfizer will hold a meeting of the Board of Directors of the Company on 07 May 2018, inter alia, to consider and take on record the Audited Financial Results of the Company for the financial year ended March 31, 2018, and to consider recommendation of dividend, if any, for the financial year ended March 31, 2018.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
